Evidence map›Paper›PMID 22737178›Full record

ArticleNano today2012

Guided Delivery of Polymer Therapeutics Using Plasmonic Photothermal Therapy.

Adam J Gormley, Nate Larson, Shraddha Sadekar, Ryan Robinson, Abhijit Ray, Hamidreza Ghandehari

Abstract read
In one paragraph

Article in Nano today, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Advances in Photothermal Therapy for Oral Cancer.International journal of molecular sciences · 2025
    Review
  2. Article
  3. Review
  4. Overcoming Vascular Barriers to Improve the Theranostic Outcomes of Nanomedicines.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2017
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Comparative effect of gold nanorods and nanocages for prostate tumor hyperthermia.Journal of controlled release : official journal of the Controlled Release Society · 2015
    Article
  19. Nanotechnology for cancer treatment.Nanotechnology reviews · 2015
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adam J GormleyDepartment of Bioengineering, University of Utah, Salt Lake City, UT, 84108, USA.
Nate Larson
Shraddha Sadekar
Ryan Robinson
Abhijit Ray
Hamidreza Ghandehari

Funding

PPARgamma Deacetylation in the Restoration of Metabolic HomeostasisR01DK112943 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI QIANG, LI · 2018 to 2022
$2.4M
Polymers for Targeted Delivery of Angiogenic InhibitorsR01EB007171 · NIBIB · UNIVERSITY OF UTAH · PI GHANDEHARI, HAMID · 2006 to 2009
$1.1M
NIBIB NIH HHS R01 EB007171NIDDK NIH HHS R01 DK112943
6 · The paper itself

Abstract

In most drug delivery systems the clinician does not have control over the location of drug delivery after the therapeutic has been administered. As the location of the tumor mass is often known in many patients, a therapy system which enables the clinician to play an active role in nanomedicine localization would provide an advantage. Here, we show a new approach wherein a laser can be used to tag tumor tissue and enhance the delivery of targeted polymer therapeutics. Plasmonic gold nanorods are delivered to the cancerous tissue and heated by a laser to promote a targetable, hyperthermic response. Concurrent administration of a heat shock targeted polymer therapeutic thereby enhances site specific delivery.

Identifiers

PMID22737178
PMCPMC3380374

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.